Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

NCT07363551 · tracked via the Priya Life Science China tracker

Sponsor

China Medical University Hospital

Phase

Not applicable

Started

2021-06-09

Last updated

2026-01-26

Condition(s) studied

ADHD

Investigational drug(s) / intervention(s)

Omega-3 fatty acidsPlacebo

Omega-3 fatty acids: omega-3 fatty acids (EPA)

Placebo: soy bean oil

Study summary

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

Eligibility

Sex

ALL

Min age

13 Years

Max age

18 Years

Healthy volunteers

Inclusion Criteria: * Youth with a DSM-5 diagnosis of MDE Exclusion Criteria: * Has a recent change in antidepressants or psychotherapy treatment within 4 weeks. * Allergic to omega-3 fatty acids

Primary outcome measure(s)

clinical symptoms — week 0,1,2,4,8,12
Hamilton Depression Rating Scale (HAMD)-21 item is a clinician-rated scale designed to assess the severity of depressive symptoms over the past week. It is commonly used in clinical trials and psychiatric practice Total Score Interpretation (Commonly Used) Total Score and Severity Level * 0-7: No depression / Normal * 8-13: Mild depression * 14-18: Moderate depression * 19-22: Severe depression -≥23: Very severe depression

Trial sites (1)

Facility	City	Region	Status
China Medical University	Taichung	Taichung	Recruiting

More China Medical University Hospital trials in China

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia Recruiting

Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss Recruiting

Imatinib and Trametinib for KRAS-mutated Solid Tumor Recruiting

Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia Starting soon

Effectiveness of an Acupressure Band for Primary Dysmenorrhea in College Students Recruiting

Other trials for the same condition

Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder Recruiting

Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD) Recruiting

Dual-target iTBS for Youth With ADHD Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07363551 on ClinicalTrials.gov ↗ ← All trials in China